Literature DB >> 4997691

The serum concentration of the third component of complement beta-1C-beta-1A in liver disease.

R A Fox, F J Dudley, S Sherlock.   

Abstract

Serum C(3) (beta(1C)/beta(1A)) has been measured in normal individuals and the range found is in agreement with findings of other authors (85-370 mg/100 ml). In 18 patients with acute hepatitis and massive necrosis serum C(3) was consistently reduced to below 50% of normal. In other patients with acute hepatitis the serum C(3) concentration was normal. In the majority of the 150 patients with chronic liver disease serum C(3) concentration was normal. However, 10 patients (six with active chronic hepatitis, four with cryptogenic cirrhosis) had hypocomplementaemia. The reason for the depression is not clear but could reflect either decreased synthesis or increased consumption, or a combination of the two.

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 4997691      PMCID: PMC1411859          DOI: 10.1136/gut.12.7.574

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  13 in total

1.  SERUM LEVELS OF BETA-1C GLOBULIN, A COMPLEMENT COMPONENT, IN THE NEPHRITIDES, LIPOID NEPHROSIS, AND OTHER CONDITIONS.

Authors:  C D WEST; J D NORTHWAY; N C DAVIS
Journal:  J Clin Invest       Date:  1964-08       Impact factor: 14.808

2.  ESTIMATION OF THE SERUM BETA-1C GLOBULIN CONCENTRATION: ITS RELATION TO THE SERUM HEMOLYTIC COMPLEMENT TITER.

Authors:  M R KLEMPERER; S P GOTOFF; C A ALPER; A S LEVIN; F S ROSEN
Journal:  Pediatrics       Date:  1965-05       Impact factor: 7.124

3.  The hypersensitive state and the liver: a critical review.

Authors:  M B GOLDGRABER; J B KIRSNER
Journal:  Am J Med Sci       Date:  1961-01       Impact factor: 2.378

4.  Serum complement levels in systemic lupus erythematosus and other diseases.

Authors:  G L ASHERSON
Journal:  Australas Ann Med       Date:  1960-02

5.  [The significance of the beta 1C-1A content in serum of patients with the so-called "lupoid" hepatitis].

Authors:  C Mueller-Eckhardt; G Kretzschmar; H A Kühn
Journal:  Klin Wochenschr       Date:  1970-04-15

6.  Complement inactivation by serum from patients with acute and hypocomplementemic chronic glomerulonephritis.

Authors:  R J Pickering; H Gewurz; R A Good
Journal:  J Lab Clin Med       Date:  1968-08

7.  Immune processes in the pathogenesis of liver disease.

Authors:  H Popper; F Paronetto; F Schaffner
Journal:  Ann N Y Acad Sci       Date:  1965-06-30       Impact factor: 5.691

8.  Topics in clinical medicine. Complement levels in disease.

Authors:  A S Townes
Journal:  Johns Hopkins Med J       Date:  1967-05

9.  Hepatitis-associated antigen and antibody in haemodialysis patients and staff.

Authors:  A H Knight; R A Fox; R A Baillod; S P Niazi; S Sherlock; J F Moorhead
Journal:  Br Med J       Date:  1970-09-12

10.  Human C'3: evidence for the liver as the primary site of synthesis.

Authors:  C A Alper; A M Johnson; A G Birtch; F D Moore
Journal:  Science       Date:  1969-01-17       Impact factor: 47.728

View more
  18 in total

Review 1.  Immunological reactivity and viral hepatitis.

Authors:  S Sherlock
Journal:  Bull N Y Acad Med       Date:  1975-04

2.  Spontaneous bacterial peritonitis: a review of treatment options.

Authors:  Cesar Alaniz; Randolph E Regal
Journal:  P T       Date:  2009-04

3.  Differences between plasma and serum complement in patients with chronic liver disease.

Authors:  S Inai; H Kitamura; T Fujita; J Kojima; K Nagaki
Journal:  Clin Exp Immunol       Date:  1976-09       Impact factor: 4.330

4.  Acute hepatitis: significance of changes in complement components.

Authors:  J A Charlesworth; S Lawrence; P A Worsdall; L P Roy; C R Boughton
Journal:  Clin Exp Immunol       Date:  1977-06       Impact factor: 4.330

5.  Acquired C3 deficiency in patients with alcoholic cirrhosis predisposes to infection and increased mortality.

Authors:  C Homann; K Varming; K Høgåsen; T E Mollnes; N Graudal; A C Thomsen; P Garred
Journal:  Gut       Date:  1997-04       Impact factor: 23.059

Review 6.  Long-incubation (virus B, HAA-associated) hepatitis.

Authors:  S Sherlock
Journal:  Gut       Date:  1972-04       Impact factor: 23.059

7.  Serum immunoglobulins, complement component levels and autoantibodies in liver disease.

Authors:  R A Thompson; R Carter; R P Stokes; A M Geddes; J A Goodall
Journal:  Clin Exp Immunol       Date:  1973-07       Impact factor: 4.330

8.  Circulating immune complexes and complement concentrations in patients with alcoholic liver disease.

Authors:  C Gluud; H Jans
Journal:  J Clin Pathol       Date:  1982-04       Impact factor: 3.411

9.  A case of active chronic hepatitis with painless erosive arthritis.

Authors:  D E Barnardo; B Vernon-Roberts; H L Currey
Journal:  Gut       Date:  1973-10       Impact factor: 23.059

10.  Clinically important immunological processes in acute and fulminant hepatitis, mainly due to hepatitis B virus.

Authors:  M K Mackenjee; P Kiepiela; R Cooper; H M Coovadia
Journal:  Arch Dis Child       Date:  1982-04       Impact factor: 3.791

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.